Overview
‘Catheter-Related Bloodstream Infection (CRBSI) - Epidemiology Forecast to 2028’ report delivers an in-depth understanding of the disease, historical and forecasted catheter-related bloodstream infection epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), Japan, APAC (China, India, Taiwan, South Korea, and Australia), LATAM (Brazil, Mexico, Argentina, and Colombia), Middle East (Saudi Arabia and the United Arab Emirates), and Russia.
Catheter-Related Bloodstream Infection Understanding
Catheter-related bloodstream infection (CRBSI) is defined as the presence of bacteremia originating from an intravascular (I.V.) Catheters (Intravascular catheters are indispensable in modern-day medical practice, particularly in intensive care units (ICUs)). CRBSI refers to bloodstream infection attributed to an intravascular catheter by quantitative culture of the catheter tip or by differences in growth between catheter and peripheral venipuncture blood culture specimens. It is also known as catheter-related sepsis. It is also the most common cause of nosocomial bacteremia.
Catheter-Related Bloodstream Infection Epidemiology Perspective by Report
The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by Total Incident Population of CRBSI, Total Diagnosed Incident Population of CRBSI, and Diagnosed Incidence of CRBSI by Causative Pathogens scenario of catheter-related bloodstream infection in the global market covering the United States, EU5 countries (Germany, France, Italy, Spain, and United Kingdom), Japan, APAC (China, India, Taiwan, South Korea, and Australia), LATAM (Brazil, Mexico, Argentina, and Colombia), Middle East (Saudi Arabia and the United Arab Emirates), and Russia from 2017 to 2028.
Catheter-Related Bloodstream Infection Detailed Epidemiology Segmentation
As per analysis, the total incident population of catheter-related bloodstream infection in the global market was found to be 4,114,882 in 2017 and the diagnosed incident population of catheter-related bloodstream infection in the global market was observed to be 3,920,865 in 2017. The estimates show a higher incidence of catheter-related bloodstream infections in India with 1,722,280 cases in 2017.
According to assessment, it has been observed among the North American countries, the United States had the highest incident population of catheter-related bloodstream infection with 328,107 cases in 2017. The total incident population of catheter-related bloodstream infection in the APAC region was found to be 3,105,930 cases in 2017, and India accounted for the highest number of cases among all the APAC countries. Among the LATAM region, Brazil accounted for the highest incidence of catheter-related bloodstream infection with 163,405 cases in 2017. Whereas, the least number of cases was contributed by Colombia. In the MENA region, Saudi Arabia shows a higher incidence of catheter-related bloodstream infection with 28,118 cases in 2017.
The estimates show that gram-positive bacteria are implicated in 65–70% of the cases of catheter-related bloodstream infection, whereas gram-negative bacteria account for 30-35% of the cases of catheter-related bloodstream infection in the US, EU5, Japan, India, South Korea, Argentina, and Mexico. Whereas, in countries like China, Taiwan, Australia, Brazil, Colombia, Saudi Arabia, UAE, and Russia, the incidence of gram-negative bacteria is higher as compared to gram-positive bacteria.
Scope of the Report
• The report covers the descriptive overview of catheter-related bloodstream infection, explaining its causes, signs and symptoms, pathogenesis and currently available therapies.
• The report provides insight into the global historical and forecasted patient pool covering the United States, EU5 countries (Germany, France, Italy, Spain, and United Kingdom), Japan, APAC (China, India, Taiwan, South Korea, and Australia), LATAM (Brazil, Mexico, Argentina, and Colombia), Middle East (Saudi Arabia and the United Arab Emirates), and Russia.
• The report helps to recognize the growth opportunities in the global market with respect to the patient population.
• The report provides the segmentation of the disease epidemiology at the global level by Total Incident Population of Catheter-Related Bloodstream Infection, Total Diagnosed Incident Population of Catheter-Related Bloodstream Infection, and Diagnosed Incidence of Catheter-Related Bloodstream Infection by Causative Pathogens.
Report Highlights
• Nine-Year Forecast of Catheter-Related Bloodstream Infection
• Global Coverage
• Total Incident Population of Catheter-Related Bloodstream Infection
• Total Diagnosed Incident Population of Catheter-Related Bloodstream Infection
• Diagnosed Incidence of Catheter-Related Bloodstream Infection by Causative Pathogens
KOL- Views
We interview, KOLs and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and incidence by the causative pathogen. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.
Key Questions Answered
• What is the disease risk, burden of catheter-related bloodstream infection?
• What is the historical catheter-related bloodstream infection patient pool in the United States, EU5 (Germany, France, Italy, Spain, and the UK), Japan, APAC (China, India, Taiwan, South Korea, and Australia), LATAM (Brazil, Mexico, Argentina, and Colombia), Middle East (Saudi Arabia and the United Arab Emirates), and Russia?
• What would be the forecasted patient pool of catheter-related bloodstream infection at the global level?
• What will be the growth opportunities across the globe with respect to the patient population pertaining to catheter-related bloodstream infection?
• Out of the above-mentioned countries, which country would have the highest Incident population of catheter-related bloodstream infection during the forecast period (2020–2028)?
• At what CAGR the population is expected to grow across the globe during the forecast period (2020–2028)?
Reasons to buy
The catheter-related bloodstream infection report will allow the user to -
• Develop business strategies by understanding the trends shaping and driving the global catheter-related bloodstream infection.
• Quantify patient populations in the global catheter-related bloodstream infection market to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the causative pathogen that presents the best opportunities for catheter-related bloodstream infection therapeutics in each of the markets covered.
• The catheter-related bloodstream infection epidemiology report and model were written and developed by Masters and Ph.D. level epidemiologists.
• The catheter-related bloodstream infection epidemiology model developed by Report is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over the nine-year forecast period using reputable sources.
Key Assessments
• Patient Segmentation
• Disease Risk and Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population
Geographies Covered
• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan
• APAC (China, India, Taiwan, South Korea, and Australia)
• LATAM (Brazil, Mexico, Argentina, and Colombia)
• Middle East (Saudi Arabia and the United Arab Emirates)
• Russia
Study Period: 2017–2028